Yahoo · Oct 7, 2026
Licence of up to 20 years, payable in shares, as Malaysia commits RM1 billion to digitalizing public healthcareKUALA LUMPUR, Malaysia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) ("Company" or "BGLC") today announced plans to build AI applications for Malaysian healthcare, following the signing of a definitive agreement with Ruanyun Edai Technology Inc. (Nasdaq: RYET) on October 5, 2026 for an exclusive Malaysian healthcare licence to RYET's CogniAI artificial intell
Benzinga · Oct 5, 2026
Ruanyun Edai Technology Inc. (NASDAQ: RYET) ("RYET" or the "Company") today announced that it has signed a definitive agreement under which, on closing, RYET would grant BioNexus Gene Lab Corp.
Yahoo · Oct 5, 2026
License of up to 20 years and reciprocal share exchange would entitle RYET to a 10% royalty on qualifying technology receipts and 560,000 BGLC shares as Malaysia accelerates public healthcare digitalizationKUALA LUMPUR, Malaysia, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (NASDAQ: RYET) (“RYET” or the “Company”) today announced that it has signed a definitive agreement under which, on closing, RYET would grant BioNexus Gene Lab Corp. (NASDAQ: BGLC) (“BGLC”) an exclusive licen